Dantrolene, a ryanodine receptor stabilizer, is a candidate immunomodulator for treating rheumatic disease

Scand J Rheumatol. 2024 May;53(3):217-219. doi: 10.1080/03009742.2023.2297519. Epub 2024 Jan 31.

Authors

T Nawata¹, T Honda², H Sakai², S Tsuji², M Otsuka², H Uchinoumi¹, S Kobayashi¹, T Yamamoto³, M Asagiri², M Yano¹

Affiliations

¹ Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.
² Department of Pharmacology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
³ Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine, Ube, Japan.

PMID: 38293969
DOI: 10.1080/03009742.2023.2297519

No abstract available

MeSH terms

Dantrolene* / therapeutic use
Humans
Immunologic Factors / therapeutic use
Muscle, Skeletal
Ryanodine Receptor Calcium Release Channel*

Substances

Dantrolene
Ryanodine Receptor Calcium Release Channel
Immunologic Factors